Introduction : novel insights into TB research and drug discovery
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), kills more people than any other bacterium. TB control is threatened by the continued spread of drug resistance; multi-drug and extensively drug resistant Mtb require longer, more costly, treatment with multiple drugs causin...
Saved in:
Main Author: | Grüber, Gerhard |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/138549 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
The unique C-terminal extension of mycobacterial F-ATP synthase subunit α is the major contributor to its latent ATP hydrolysis activity
by: Wong, Chui-Fann, et al.
Published: (2021) -
Rapid integrative approach to MDRTB diagnosis through TB-TNT
by: Heralde, Francisco M., III, et al.
Published: (2010) -
Oxidative phosphorylation — an update on a new, essential target space for drug discovery in mycobacterium tuberculosis
by: Foo, Caroline Shi-Yan, et al.
Published: (2020) -
Atomic structure of the regulatory TGS domain of Rel protein from Mycobacterium tuberculosis and its interaction with deacylated tRNA
by: Shin, Joon, et al.
Published: (2022) -
Atomic structure of, and valine binding to the regulatory ACT domain of the Mycobacterium tuberculosis Rel protein
by: Shin, Joon, et al.
Published: (2021)